Vivian Y. Shi, MD

  • Assistant Professor, Medicine (Dermatology) – Tenure Track
  • Director, Eczema Specialty Clinic
  • Director, Hidradenitis Suppurativa Specialty Clinic
  • Director, Inflammatory Skin Research Fellowship Program

Clinical and Research Interests: 
- Eczematous Skin disorders: Atopic Dermatitis, Contact Dermatitis, Hand Dermatitis.
- Hidradenitis Suppurativa
- Psoriasis
- General Skin Dermatology and Skin Cancers

Education Interests:
Dr. Shi is the director for Inflammatory Skin Disease Research Fellowship Program. She is also the faculty advisor for the Dermatology Interest Group at the University of Arizona College of Medicine – Tucson. 

Community Interests:
Dr. Shi is dedicated to community and global outreach for the underserved and volunteers with medical students at Tucson's homeless clinics as part of the COM CUP (Commitment to the Underserved People) Program. She has completed medical outreach trips to serve patients in remote areas of India, Burma, China, Vietnam and Mexico. 

Research Interests: 

Dr. Shi serves as the principal investigator on multiple industry-sponsored and investigator-initiated clinical and translational studies. 

Her research interest include: 

  • The effect of targeted topical and systemic therapies for atopic dermatitis, hidradenitis suppurativa, hand dermatitis, and psoriasis.
  • Noninvasive evaluation and repair of skin barrier function.
  • Optimizing transepidermal drug delivery.
  • Oxidative stress in atopic dermatitis and hidradenitis suppurativa.

Her current collaborations at UA consist of:

  • The Department of Immunobiology on immune dysregulation of hidradenitis suppurativa, and microbiome alteration in atopic dermatitis.
  • The Division of Infectious Diseases on the dermatologic effects of long term treatment for Valley fever (Coccidioidomycosis).
  • The UA College of Optical Sciences to develop novel multi-modal techniques to detect and evaluate skin inflammation and barrier defects. 
Degrees
  • MD: University of Illinois at Chicago, College of Medicine
  • BS: University of California, Los Angeles, Physiological Sciences
Honors and Awards
  • Excellence in Dermatology Research Award, Skin Active Scientific
  • Patient-Centered Investigation Award, Dermatology Foundation
  • National Postgraduate Award, Alpha Omega Alpha Honor Medical Society
  • Albert M. Kligman Fellowship, Society of Investigative Dermatology
Residency
  • Dermatology, Chief Resident, University of California, Davis
  • Dermatology, University of California, Davis
Internship
  • Internal Medicine, University of Chicago/NorthShore University Health Systems
Fellowship
  • Skin Immunology Laboratory, University of Illinois at Chicago
Board Certifications
  • Arizona Medical Board, Medical License
  • California Medical Board, Medical License
  • American Board of Dermatology, 2016

Select Publications

2017

Kartan, S., V. Y. Shi, A. K. Clark, and L. S. Chan, "Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment.", Am J Clin Dermatol, vol. 18, issue 1, pp. 105-126, 2017 Feb. PMID: 27878477
Trusler, A. R., A. K. Clark, R. K. Sivamani, and V. Y. Shi, "The Endocannabinoid System and Its Role in Eczematous Dermatoses.", Dermatitis, vol. 28, issue 1, pp. 22-32, 2017 Jan/Feb. PMID: 28098721
Vaughn, A. R., P. Tannhauser, R. K. Sivamani, and V. Y. Shi, "Mother Nature in Eczema: Maternal Factors Influencing Atopic Dermatitis.", Pediatr Dermatol, vol. 34, issue 3, pp. 240-246, 2017 May. PMID: 28523877

2016

Tran, K. A., M. Y. Cheng, A. Mitra, H. Ogawa, V. Y. Shi, L. P. Olney, A. M. Kloxin, and E. Maverakis, "MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy.", Drug Des Devel Ther, vol. 10, pp. 43-52, 2016. PMCID: PMC4694671  PMID: 26730180
Wilken, R., M. A. Fung, V. Y. Shi, M. Y. Cheng, F. Patel, H. Sultani, and E. Maverakis, "Cyclosporine-induced sebaceous hyperplasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event.", Dermatol Online J, vol. 22, issue 1, 2016 Jan 15. PMID: 26990469